Man Group PLC Castle Biosciences Inc Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Man Group PLC holds 9,600 shares of CSTL stock, worth $305,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,600
Previous 23,057
58.36%
Holding current value
$305,280
Previous $510,000
59.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
189Shares Held
26.4MCall Options Held
517KPut Options Held
15.1K-
Black Rock Inc. New York, NY3.04MShares$96.8 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$74 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$55.6 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$48.9 Million0.03% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$39.9 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $836M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...